Don Callahan
Known title: DirectorCIK: 0001433990
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Innodata Opens Robotics Lab, Eyes Speech Revenue Growth. Innodata announced the launch of a robotics lab, signaling a push into automation. The company is also exploring a 7‑language speech platform that could add new revenue streams. Analysts compare it to BigBear.ai, noting similar growth potential in the small‑cap tech space. These developments may shape investor perception of the company’s future prospects.
Transaction History
| WEX | ▲ Buy | Grant | 186 | — | 6/30/2026 | View on chart |
| INOD | ▲ Buy | Grant | 1,481 | $0 | 6/4/2026 | View on chart |
| WEX | ▲ Buy | Option Exercise | 1,567 | $0 | 5/15/2026 | View on chart |
| WEX | ▲ Buy | Grant | 171 | — | 3/31/2026 | View on chart |
| WEX | ▲ Buy | Grant | 176 | — | 12/31/2025 | View on chart |
| INOD | ▲ Buy | Grant | 1,673 | $0 | 11/11/2025 | View on chart |
| WEX | ▲ Buy | Grant | 166 | — | 9/30/2025 | View on chart |
| WEX | ▲ Buy | Grant | 178 | — | 6/30/2025 | View on chart |
| WEX | ▲ Buy | Option Exercise | 960 | $0 | 5/9/2025 | View on chart |
| WEX | ▲ Buy | Grant | 167 | — | 4/8/2025 | View on chart |
| WEX | ▲ Buy | Grant | 149 | — | 1/7/2025 | View on chart |
| WEX | ▲ Buy | Grant | 125 | — | 10/4/2024 | View on chart |
| WEX | ▲ Buy | Grant | 148 | — | 7/3/2024 | View on chart |
| WEX | ▲ Buy | Option Exercise | 1,147 | $0 | 5/11/2024 | View on chart |
| WEX | ▲ Buy | Grant | 110 | — | 4/4/2024 | View on chart |
| WEX | ▲ Buy | Grant | 134 | — | 1/23/2024 | View on chart |
| WEX | ▲ Buy | Grant | 139 | — | 10/13/2023 | View on chart |
| WEX | ▲ Buy | Grant | 147 | — | 7/13/2023 | View on chart |
| WEX | ▲ Buy | Option Exercise | 1,030 | $0 | 5/12/2023 | View on chart |
| WEX | ▲ Buy | Grant | 149 | — | 4/11/2023 | View on chart |
| WEX | ▲ Buy | Grant | 160 | — | 1/10/2023 | View on chart |
| WEX | ▲ Buy | Grant | 206 | — | 10/11/2022 | View on chart |
| WEX | ▲ Buy | Grant | 168 | — | 7/15/2022 | View on chart |
| WEX | ▲ Buy | Option Exercise | 760 | $0 | 6/4/2022 | View on chart |
| WEX | ▲ Buy | Grant | 147 | — | 4/15/2022 | View on chart |
| WEX | ▲ Buy | Grant | 186 | — | 1/13/2022 | View on chart |
| WEX | ▲ Buy | Grant | 149 | — | 10/12/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
WEX Shares Stretch as Company Expands AI Claims Tool
WEX is expanding its AI claims tool, a move that has pushed the stock higher but also stretched its valuation. The shares are trading near the $148.41 support level, which has been tested 10 times. Investors are watching how the new AI features will impact the company’s earnings and pricing.
WEX Shares Stretch as Company Expands AI Claims Tool. WEX is expanding its AI claims tool, a move that has pushed the stock higher but also stretched its valuation. The shares are trading near the $148.41 support level, which has been tested 10 times. Investors are watching how the new AI features will impact the company’s earnings and pricing.